vascular dementia: A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3715 |
4. Check minimum number of eventsNone |
3715 |
5. Include endpointsNone |
3715 |
6. Filter based on genotype QC (FinnGen only) |
3715 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F00-F03
- Name in latin
- Dementia vascularis
Similar endpoints
↥List of similar endpoints to
Vascular dementia
based on the number of shared cases.
Similar with more cases:
- Dementia
- Dementia, including avohilmo
- Organic, including symptomatic, mental disorders
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 65659 | 37270 | 27252 |
| Only index persons | 40397 | 23852 | 16545 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.94 | 1.07 | 0.76 |
| Only index persons | 0.78 | 0.88 | 0.63 |
| Median age at first event (years) | |||
| Whole population | 82.41 | 84.09 | 80.27 |
| Only index persons | 83.66 | 85.41 | 81.13 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3715 | 1408 | 2307 |
| Unadjusted period prevalence (%) | 0.81 | 0.48 | 1.02 |
| Median age at first event (years) | 80.95 | 82.74 | 79.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3220
- Matched controls
- 31293
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F03
ICD-10 Finland
Unspecified dementia
46.2
323.0
775
213
N06DX01
ATC
memantine; oral
83.8
323.0
666
97
F01.9
ICD-10 Finland
Vascular dementia, unspecified
759.7
323.0
1490
36
N05AX08
ATC
risperidone; systemic
11.7
323.0
776
827
G30.1
ICD-10 Finland
Alzheimer disease with late onset
21.6
323.0
496
261
N06DA02
ATC
donepezil; oral
64.5
323.0
486
86
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
201.0
323.0
446
25
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
315.7
301
*
F01.2
ICD-10 Finland
Subcortical vascular dementia
282.6
309.8
315
12
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
487.7
278.5
277
6
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.0
264.1
732
1267
N06DA03
ATC
rivastigmine; oral, transdermal
89.1
260.3
292
35
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
2337.5
242.1
234
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
4.9
239.6
924
2362
N05AH04
ATC
quetiapine; oral
6.3
228.8
679
1267
P20
ICPC
Memory disturbance
4.4
203.0
876
2454
N06DA04
ATC
galantamine; oral
103.7
198.5
219
22
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
142.4
192.6
206
15
F01.0
ICD-10 Finland
Vascular dementia of acute onset
957.2
189.6
186
*
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
266.3
176.6
181
7
F01.1
ICD-10 Finland
Multi-infarct dementia
+∞
174.8
168
*
F01
ICD-10 Finland
Vascular dementia
83.9
165.2
187
23
R53
ICD-10 Finland
Malaise and fatigue
3.2
157.6
1089
4349
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.3
154.6
979
3661
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
19.2
147.8
232
126
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
496.4
147.1
147
*
G30.8
ICD-10 Finland
Other Alzheimer disease
30.2
135.4
185
63
R41.0
ICD-10 Finland
Disorientation, unspecified
6.8
131.9
356
560
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
124.8
1408
7354
A28
ICPC
Limited function/disability NOS
2.8
122.7
998
4299
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
38.4
117.1
151
40
P70
ICPC
Dementia
14.1
108.4
191
139
SPAT1053
SPAT
Memory test
2.7
103.1
843
3576
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
28.7
98.5
136
48
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
250.6
97.1
100
*
N06AB04
ATC
citalopram; systemic
2.7
93.8
801
3458
F05.1
ICD-10 Finland
Delirium superimposed on dementia
40.0
93.2
119
30
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.2
92.1
550
1879
AA1AD
NOMESCO Finland
CT of head and brain
2.4
90.3
1046
5304
R41.3
ICD-10 Finland
Other amnesia
6.8
88.3
234
354
N03AG01
ATC
valproic acid; systemic, rectal
6.0
84.0
246
425
N06AX11
ATC
mirtazapine; oral
2.3
83.9
972
4894
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
77.6
1383
8369
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
76.1
905
4571
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
375.4
75.2
76
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
9.7
75.1
158
165
N05BA04
ATC
oxazepam; oral
2.3
74.2
880
4433
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.1
73.3
313
808
N06AB10
ATC
escitalopram; oral
3.1
69.1
434
1516
F05.9
ICD-10 Finland
Delirium, unspecified
5.9
67.3
197
339
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
66.9
708
3348
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
139.0
65.4
70
5
L28
ICPC
Limited function/disability (L)
2.3
65.1
766
3806
A06AD11
ATC
lactulose; oral
2.1
62.3
902
4899
N05AH03
ATC
olanzapine; systemic
6.6
60.9
163
249
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
571.9
58.2
58
*
N05AD01
ATC
haloperidol; systemic
4.1
58.2
240
597
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
151.0
57.4
61
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
54.5
474
2002
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
54.3
665
3329
N05AD03
ATC
melperone; systemic
5.9
54.0
158
271
SPAT1216
SPAT
Assessment of functional ability
2.2
53.8
686
3494
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
52.7
671
3411
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
67.0
52.6
61
9
4378A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MULTI-INFARKTIDEMENTIA]
+∞
50.6
49
*
F01.8
ICD-10 Finland
Other vascular dementia
92.3
50.3
56
6
G30
ICD-10 Finland
Alzheimer disease
32.8
47.6
63
19
N02BE01
ATC
paracetamol; systemic, rectal
1.8
46.2
2361
18977
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
46.1
386
1586
F06.7
ICD-10 Finland
Mild cognitive disorder
4.4
45.5
172
393
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.1
44.5
265
882
WYA20
NOMESCO Finland
Home visit
6.0
44.2
127
213
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.7
43.5
200
546
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
42.8
450
2075
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
42.7
226
690
S72.0
ICD-10 Finland
Fracture of neck of femur
2.7
42.5
325
1267
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
110.8
41.3
45
*
S01.0
ICD-10 Finland
Open wound of scalp
2.6
41.2
324
1282
F0019, G301
ICD-10 Finland
NA
+∞
40.3
39
*
N30.0
ICD-10 Finland
Acute cystitis
2.1
39.7
498
2484
R55
ICD-10 Finland
Syncope and collapse
2.1
39.2
509
2575
130
Kela drug reimbursment
Malignant tumour
0.2
38.9
51
2074
R42
ICD-10 Finland
Dizziness and giddiness
1.8
37.4
821
5031
Z75.5
ICD-10 Finland
Holiday relief care
5.5
37.3
114
207
F01.14
ICD-10 Finland
Multi-infarct dementia's other mixed symptoms of mixed type
+∞
37.2
36
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.5
37.1
308
1253
S06.0
ICD-10 Finland
Concussion
2.4
36.9
341
1470
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
+∞
36.1
35
*
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
36.1
35
*
F009, G309
ICD-10 Finland
NA
+∞
36.1
35
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.8
36.0
158
415
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
35.0
2040
16232
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
34.7
238
867
SPAT1254
SPAT
Administration of medicine
1.9
34.3
578
3220
I95.1
ICD-10 Finland
Orthostatic hypotension
2.8
33.6
227
818
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
33.6
235
866
N06AX26
ATC
vortioxetine; oral
4.5
33.0
120
264
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
32.8
963
6386
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
5.5
32.7
100
182
W19
ICD-10 Finland
Unspecified fall
2.2
32.5
347
1602
B01AC07
ATC
dipyridamole; systemic
2.0
31.7
457
2396
K90
ICPC
Stroke/cerebrovascular accident
3.3
31.3
166
508
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
31.2
288
1235
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.9
31.2
201
704
XA800
NOMESCO Finland
Neuropsychological investigation
5.3
31.1
98
185
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
31.0
478
2569
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.9
30.3
196
688
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
29.4
269
1151
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
104.7
29.3
32
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.0
29.1
96
191
N30.9
ICD-10 Finland
Cystitis, unspecified
2.5
28.9
246
1012
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
28.9
28
*
SPAT1234
SPAT
Support of social functional capacity
2.5
28.6
238
968
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
147.0
28.3
30
*
A04
ICPC
Weakness/tiredness general
1.9
27.9
450
2452
F01.22
ICD-10 Finland
Subcortical vascular dementia with additional symptoms, mainly hallucinations
+∞
27.9
27
*
E86
ICD-10 Finland
Volume depletion
3.1
27.5
159
518
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
27.2
579
3465
SPAT1360
SPAT
Extensive global examination
2.3
27.1
266
1176
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.7
26.7
187
689
G30.0
ICD-10 Finland
Alzheimer disease with early onset
25.9
26.7
37
14
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
26.5
587
3555
A10AE04
ATC
insulin glargine; parenteral
2.1
26.4
322
1569
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.5
25.7
93
205
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.2
25.3
139
437
U04
ICPC
Incontinence urine
2.6
25.1
192
746
J01CA08
ATC
pivmecillinam; oral
1.5
24.5
979
6913
S70.0
ICD-10 Finland
Contusion of hip
2.6
24.4
187
726
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
88.2
24.4
27
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
24.3
399
2184
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
24.1
170
629
H02AB02
ATC
dexamethasone; systemic
0.3
24.0
46
1539
J01DB01
ATC
cefalexin; oral
1.5
23.9
1959
16079
TAB00
NOMESCO Finland
Lumbar puncture
4.3
23.8
91
212
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
4.8
23.8
81
168
C10AA01
ATC
simvastatin; oral
1.5
23.6
1583
12462
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
22.9
490
2923
Z02.7
ICD-10 Finland
Issue of medical certificate
2.4
22.3
193
803
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
21.9
214
941
Z3226
NOMESCO Finland
Physiotherapist
1.7
21.9
526
3244
R4110
NOMESCO Finland
Physiotherapy
1.6
21.7
683
4528
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.7
21.5
152
564
F05.8
ICD-10 Finland
Other delirium
6.2
21.4
58
92
N03AF02
ATC
oxcarbazepine; oral
3.5
21.4
103
294
F01.33
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression
215.1
21.4
22
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
21.3
675
4477
F21
ICPC
NA
4.9
21.2
70
141
Z2445
NOMESCO Finland
Psychologist
4.9
20.7
68
136
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
20.7
176
724
F01.11
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly paranoidism
+∞
20.6
20
*
R33
ICD-10 Finland
Retention of urine
1.8
20.6
411
2396
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.2
20.5
64
121
N02AA05
ATC
oxycodone; systemic
1.6
20.4
565
3617
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
205.3
20.4
21
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.9
20.0
123
420
J01EA01
ATC
trimethoprim; systemic
1.5
19.9
854
6065
K91
ICPC
Cerebrovascular disease
4.0
19.7
80
198
F00
ICD-10 Finland
Dementia in Alzheimer disease
20.3
19.6
29
14
C03CA01
ATC
furosemide; systemic
1.4
19.3
1614
13040
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
19.1
974
7166
SPAT1229
SPAT
Assessment of need for aid
1.9
19.1
311
1690
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.3
18.9
179
779
SPAT1172
SPAT
Guidance concerning hydration
2.7
18.8
135
506
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.3
18.8
71
165
F01.31
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism
+∞
18.6
18
*
F22.0
ICD-10 Finland
Delusional disorder
5.0
18.5
60
119
Z3231
NOMESCO Finland
Registered nurse
1.5
18.5
781
5512
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
18.5
335
5053
A10BA02
ATC
metformin; oral
1.5
18.1
934
6870
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
18.1
354
2045
ZXD05
NOMESCO Finland
Urgent procedure
1.5
17.8
906
6639
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.1
17.8
207
989
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
14.0
17.7
30
21
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
17.7
409
2481
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
17.7
457
2861
N05CD07
ATC
temazepam; oral
1.5
17.7
613
4132
F0009, G300
ICD-10 Finland
NA
+∞
17.5
17
*
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
17.5
17
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
17.5
465
2935
N06AB06
ATC
sertraline; oral
2.2
17.5
174
775
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
16.9
350
2056
F01.12
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly hallucinations
+∞
16.5
16
*
F01.32
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations
+∞
16.5
16
*
F0029, G308
ICD-10 Finland
NA
+∞
16.5
16
*
B01AA03
ATC
warfarin; systemic
1.4
16.5
1099
8448
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
16.4
162
718
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
16.4
272
1487
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.5
16.1
57
125
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
3.9
16.0
66
167
C07AB07
ATC
bisoprolol; oral
1.4
15.9
1681
13936
N05AB03
ATC
perphenazine; systemic, rectal
3.0
15.8
92
304
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.3
15.7
154
681
J01MA02
ATC
ciprofloxacin; systemic
1.4
15.6
1200
9431
N06AX21
ATC
duloxetine; oral
2.1
15.5
177
839
Y94.0
ICD-10 Finland
Accident at home
3.2
15.4
82
255
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
15.3
576
3947
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2.1
15.2
175
830
ZXD35
NOMESCO Finland
Usual procedure
2.5
15.2
123
493
N06AX16
ATC
venlafaxine; oral
2.1
15.1
175
835
A10AE05
ATC
insulin detemir; parenteral
2.2
15.1
160
735
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
14.9
265
4039
R4120
NOMESCO Finland
Occupational therapy
2.2
14.9
154
698
A10BB12
ATC
glimepiride; oral
1.6
14.9
380
2368
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.8
14.8
95
334
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
14.7
331
1991
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
14.6
626
4407
F01.81
ICD-10 Finland
Other specified vascular dementia has other additional symptoms, mainly paranoidism
55.3
14.6
17
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
14.5
11
623
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
14.4
14
*
A29
ICPC
General symptom/complaint other
1.7
14.4
312
1857
G04BD07
ATC
tolterodine; oral
1.9
14.3
231
1251
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
14.2
104
396
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
14.2
241
1326
B01AC04
ATC
clopidogrel; oral
1.5
14.1
630
4468
SPAT1167
SPAT
Insertion of urinary catheter
2.1
14.1
153
711
G04CA02
ATC
tamsulosin; oral
1.4
14.0
1013
7842
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.0
13.8
44
87
E000001
ATC
NA
1.5
13.8
485
3266
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.6
13.6
96
359
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.8
13.5
87
307
WX212
NOMESCO Finland
Femoral plexus blockade
2.8
13.5
85
298
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.0
13.5
171
848
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.2
13.3
70
217
C09AA05
ATC
ramipril; oral
1.4
13.3
910
6968
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
20.6
13.1
19
9
N03AX14
ATC
levetiracetam; systemic
3.3
13.0
64
189
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
11.2
13.0
24
21
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.9
13.0
52
130
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
5.6
12.9
37
65
N06AB03
ATC
fluoxetine; oral
1.8
12.8
236
1336
G04BD04
ATC
oxybutynin; oral, transdermal
1.7
12.7
251
1451
SPAT1262
SPAT
Handing over of treatment supplies
1.5
12.6
477
3263
R32
ICD-10 Finland
Unspecified urinary incontinence
2.6
12.4
93
360
R11
ICD-10 Finland
Nausea and vomiting
1.7
12.4
248
1442
F01.13
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly depression
+∞
12.4
12
*
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
+∞
12.4
12
*
C08CA01
ATC
amlodipine; oral
1.3
12.3
1168
9385
N18
ICPC
Paralysis/weakness
2.9
12.3
74
253
SPAT1301
SPAT
No procedures
1.4
12.1
835
6387
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.7
12.1
51
134
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
12.0
1155
9295
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
11.9
179
948
EBA30
NOMESCO Finland
Excision of root of tooth
2.1
11.9
137
654
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
11.8
184
983
N29
ICPC
Neurological sympt/complt other
3.4
11.8
56
162
SPAT1153
SPAT
Removal of sutures
0.7
11.7
433
5717
C10AA05
ATC
atorvastatin; oral
1.3
11.6
1069
8535
R1260
NOMESCO Finland
Evaluation of communicative skills
2.9
11.6
69
234
Z2221
NOMESCO Finland
Medical doctor
1.4
11.6
670
4966
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
11.3
945
7427
F0014, G301
ICD-10 Finland
NA
+∞
11.3
11
*
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
4.4
11.2
39
86
I67.2
ICD-10 Finland
Cerebral atherosclerosis
4.2
11.2
41
95
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
2.7
11.2
74
268
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
2.4
11.2
91
369
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
14.7
11.1
18
12
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.6
11.0
78
294
S06.3
ICD-10 Finland
Focal brain injury
3.3
11.0
55
166
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.3
11.0
97
412
N05CF01
ATC
zopiclone; oral
1.3
11.0
1083
8717
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.3
11.0
39
88
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.2
10.8
111
504
SPAT1101
SPAT
Orthostatic test
1.8
10.8
176
959
ZXA05
NOMESCO Finland
Left side
1.4
10.8
768
5883
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
5.9
10.7
29
48
A02BC02
ATC
pantoprazole; systemic
1.3
10.7
1636
13957
N03AX09
ATC
lamotrigine; oral
3.5
10.4
47
132
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
10.3
918
7264
R44.1
ICD-10 Finland
Visual hallucinations
5.8
10.3
28
47
N28
ICPC
Limited function/disability (N)
3.3
10.2
51
154
315
Kela drug reimbursment
Clopidogrel
2.6
10.2
72
272
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.0
10.1
58
191
T90.5
ICD-10 Finland
Sequelae of intracranial injury
5.1
10.1
31
60
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
10.0
200
1164
A10BH01
ATC
sitagliptin; oral
1.6
9.9
265
1667
N03AF01
ATC
carbamazepine; oral, rectal
1.8
9.9
175
980
P29
ICPC
Psychological sympt/compl other
2.9
9.9
57
190
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
3.1
9.9
52
164
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.6
9.8
43
118
I63.8
ICD-10 Finland
Other cerebral infarction
3.1
9.8
52
165
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.9
9.8
140
729
S22.3
ICD-10 Finland
Fracture of rib
1.8
9.7
180
1022
G04BD08
ATC
solifenacin; oral
1.7
9.7
209
1244
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
11.9
9.7
17
14
W06
ICD-10 Finland
Fall involving bed
3.3
9.6
46
135
ZXA00
NOMESCO Finland
Right side
1.3
9.6
796
6227
N05AA02
ATC
levomepromazine; systemic
2.0
9.6
116
567
R44.3
ICD-10 Finland
Hallucinations, unspecified
6.1
9.6
25
40
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.2
9.6
97
438
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
9.6
163
901
R47.0
ICD-10 Finland
Dysphasia and aphasia
3.0
9.6
52
168
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.2
9.5
9
445
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
9.5
499
3625
R54
ICD-10 Finland
Senility
3.4
9.4
44
127
205
Kela drug reimbursment
Chronic hypertension
1.3
9.4
1263
10533
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.6
9.4
64
238
SPAT1165
SPAT
Peritoneal dialysis
8.8
9.3
19
21
S00.0
ICD-10 Finland
Superficial injury of scalp
2.4
9.3
76
310
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.4
9.3
43
124
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.3
9.2
17
577
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.0
9.2
114
564
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
9.2
665
5090
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.0
9.2
115
568
P99
ICPC
Psychological disorders other
4.3
9.2
33
76
S01
ICD-10 Finland
Open wound of head
3.2
9.1
45
136
G21.8
ICD-10 Finland
Other secondary parkinsonism
8.4
9.1
19
22
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.7
9.1
178
1030
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
3.6
9.1
39
106
S20.2
ICD-10 Finland
Contusion of thorax
1.9
8.9
124
642
T90
ICPC
Diabetes non-insulin dependent
1.4
8.9
560
4188
G04BD12
ATC
mirabegron; oral
1.5
8.9
274
1784
EBA00
NOMESCO Finland
Extraction of tooth
1.4
8.9
556
4156
N05AX12
ATC
aripiprazole; systemic
4.7
8.9
29
61
S09.9
ICD-10 Finland
Unspecified injury of head
3.5
8.9
40
113
G72.8
ICD-10 Finland
Other specified myopathies
2.5
8.9
67
262
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.2
8.9
92
422
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
6.1
8.8
23
37
G20
ICD-10 Finland
Parkinson disease
2.0
8.8
114
572
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.3
8.7
16
543
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.1
8.7
91
419
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.5
8.7
38
105
SPAT1252
SPAT
Overall medication plan or its review
1.6
8.7
220
1368
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.9
8.6
50
168
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.8
8.6
35
91
SPAT1251
SPAT
Organisation of medication
1.8
8.6
144
795
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.6
8.6
62
237
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.1
8.6
91
424
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
8.6
239
1522
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
8.6
195
1178
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
8.6
70
289
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
48.7
8.6
10
*
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
8.5
277
1827
A46
ICD-10 Finland
Erysipelas
1.4
8.5
430
3100
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
4.4
8.5
29
64
SPAT1255
SPAT
Intravenous administration of medicine
1.7
8.5
169
982
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
8.4
239
1527
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
8.4
71
297
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
15.8
8.4
13
8
SPAT1138
SPAT
Guidance concerning bowel function
2.6
8.4
61
235
H53.4
ICD-10 Finland
Visual field defects
2.4
8.3
70
292
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
8.3
459
3362
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.0
8.3
*
232
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.4
8.3
530
3978
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
8.2
8
*
F00, F03
ICD-10 Finland
NA
+∞
8.2
8
*
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
8.2
128
691
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.9
8.2
121
640
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
10.5
8.1
15
14
A10BB01
ATC
glibenclamide; oral
1.5
8.1
316
2169
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
2.1
8.1
85
395
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.6
8.1
220
1394
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
8.0
541
4088
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.2
7.9
10
416
P03
ICPC
Feeling depressed
2.2
7.9
78
350
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.9
7.9
46
156
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
21.4
7.9
11
5
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
3.3
7.9
37
109
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.5
7.8
34
94
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.7
7.8
141
799
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.6
7.8
166
2443
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.5
7.7
34
95
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.3
7.7
67
286
F001, G301
ICD-10 Finland
NA
43.8
7.6
9
*
SPAT1304
SPAT
Counselling and guidance related to ageing
1.5
7.6
260
1734
A23
ICPC
Risk factor NOS
2.0
7.6
92
452
I63
ICD-10 Finland
Cerebral infarction
3.1
7.6
39
123
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.2
7.6
9
388
C04AE01
ATC
ergoloid mesylates; systemic
2.6
7.6
52
194
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
7.5
657
5154
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.1
7.5
83
394
U13
ICPC
Bladder symptom/complaint other
2.1
7.5
76
348
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.4
7.5
39
847
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
7.5
486
3646
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
7.5
227
1473
SPAT1139
SPAT
Nutrition survey
2.0
7.5
87
420
Z60.8
ICD-10 Finland
Other problems related to social environment
5.7
7.5
20
34
G46.8
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
17.9
7.5
11
6
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
7.5
139
792
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
7.5
87
423
N05AF01
ATC
flupentixol; systemic
2.9
7.5
43
145
U28
ICPC
Limited function/disability (U)
2.8
7.4
45
158
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
7.4
177
1083
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
7.4
994
8225
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.9
7.4
109
575
K08.3
ICD-10 Finland
Retained dental root
1.7
7.4
149
872
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
7.4
111
592
F06.0
ICD-10 Finland
Organic hallucinosis
9.8
7.4
14
14
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.6
7.4
31
84
F01.83
ICD-10 Finland
Other specified vascular dementia other additional symptoms, mainly depression
78.0
7.3
8
*
R31
ICD-10 Finland
Unspecified haematuria
1.4
7.3
358
2566
SPAT1127
SPAT
Enema
2.8
7.3
43
148
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
7.3
1206
10214
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.0
7.3
94
474
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
4.7
7.2
23
48
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
+∞
7.2
7
*
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
7.2
268
1821
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
4.9
7.2
22
44
N06AA12
ATC
doxepin; systemic
1.6
7.2
160
961
A04AA02
ATC
granisetron; systemic, transdermal
0.4
7.2
21
571
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.9
7.1
41
138
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.9
7.1
41
138
F32
ICD-10 Finland
Depressive episode
2.3
7.1
60
253
S97
ICPC
Chronic ulcer skin
1.6
7.1
166
1013
SPAT1312
SPAT
General health counselling
0.7
7.1
388
4860
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.5
7.1
271
1853
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
2.4
7.1
56
228
H3601, E113
ICD-10 Finland
NA
2.3
7.0
60
255
Z43.5
ICD-10 Finland
Attention to cystostomy
3.3
7.0
33
98
H02AA02
ATC
fludrocortisone; oral
3.0
7.0
38
125
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
7.0
382
2789
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.6
7.0
29
78
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.8
7.0
106
569
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
7.0
257
1746
R4130
NOMESCO Finland
Speech therapy
2.3
7.0
59
250
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
6.9
17
503
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
2.9
6.9
40
135
ZXE00
NOMESCO Finland
One hour or less
1.2
6.9
934
7725
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.9
6.9
97
505
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.9
293
2046
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
6.8
110
600
F10.24
ICD-10 Finland
Alcohol depence active use
4.6
6.8
22
47
Z28
ICPC
Limited function/disability (Z)
4.2
6.8
24
56
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.0
6.8
36
117
R1250
NOMESCO Finland
Evaluation of functional capability
2.7
6.8
42
151
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
6.7
861
7071
N19
ICPC
Speech disorder
2.9
6.7
39
133
R51.80
ICD-10 Finland
Headache
1.5
6.7
215
1416
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.7
676
5395
D21
ICPC
Swallowing problem
2.6
6.7
47
179
P15
ICPC
Chronic alcohol abuse
3.2
6.7
33
102
L57.0
ICD-10 Finland
Actinic keratosis
0.7
6.7
195
2698
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
6.7
377
2770
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.7
6.6
41
147
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
6.5
6.6
16
24
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
6.6
50
198
H3600, E113
ICD-10 Finland
NA
2.3
6.6
56
235
XF606
NOMESCO Finland
Ortostatic test
3.6
6.6
28
77
N05BE01
ATC
buspirone; oral
2.5
6.6
50
199
E000003
ATC
NA
1.9
6.6
95
501
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
6.6
15
455
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
6.6
238
1606
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
5.9
6.6
17
28
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
2.1
6.6
72
343
S42.4
ICD-10 Finland
Fracture of lower end of humerus
2.9
6.6
38
129
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
3.3
6.5
30
88
SPAT1125
SPAT
Stoma care and guidance
2.1
6.5
66
304
R50.9
ICD-10 Finland
Fever, unspecified
1.4
6.5
346
2517
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
4.0
6.5
24
59
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.3
6.5
16
467
Y94.8
ICD-10 Finland
Other leisure activity accident
2.3
6.5
55
233
S82
ICPC
Naevus/mole
0.6
6.4
88
1428
N05AC02
ATC
thioridazine; oral
2.6
6.4
43
162
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.6
6.4
43
162
N05BA01
ATC
diazepam; systemic, rectal
1.4
6.4
351
2564
G04BD09
ATC
trospium; oral
1.9
6.4
83
423
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.4
444
3370
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.2
6.3
62
282
R40.2
ICD-10 Finland
Coma, unspecified
2.7
6.3
39
141
N06AG02
ATC
moclobemide; oral
1.9
6.3
88
459
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
6.3
13
412
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.3
616
4897
K28
ICPC
Limited function/disability (K)
1.9
6.3
82
419
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
1.8
6.2
92
490
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
1.9
6.2
86
447
SPAT1058
SPAT
PEF monitoring instruction
0.5
6.2
57
1031
N17
ICPC
Vertigo/dizziness
1.4
6.2
287
2032
A04AA01
ATC
ondansetron; systemic, rectal
0.5
6.2
40
806
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
6.2
213
2863
8731A
ICD-9 Finland
Other open wound of head, Scalp, complicated
+∞
6.2
6
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.8
6.2
93
498
QAB00
NOMESCO Finland
Suture of skin of head or neck
2.7
6.2
40
146
D07AA02
ATC
hydrocortisone; topical
1.4
6.2
286
2032
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
3.0
6.2
33
109
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.5
6.1
40
801
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.2
6.1
30
93
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
1.8
6.1
102
565
A01
ICPC
Pain general/multiple sites
1.6
6.0
167
1065
N43
ICPC
Neurological, Other diagnostic procedure
4.2
6.0
21
49
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
0.3
6.0
12
387
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.3
6.0
52
222
T89
ICPC
Diabetes insulin dependent
2.4
6.0
49
203
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
1243
6190
2.41
127.31
2.0
1.8
nmol/l
1050.1
1162.6
4.30
926
4511
(3009466) Valproate [Moles/volume] in Serum or Plasma
134
161
8.30
99.14
3.5
3.4
umol/l
321.3
325.3
0.09
105
134
(3026008) Bacteria identified in Urine by Culture
1446
8954
1.92
74.97
4.6
3.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1349
8426
1.86
65.99
4.6
4.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
72
75
9.44
59.41
1.0
1.0
ng/l
626.2
723.9
0.69
47
37
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
72
75
9.44
59.41
1.0
1.0
ng/l
47.8
34.0
1.60
51
36
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
70
75
9.17
56.56
1.0
1.0
ng/l
349.7
275.8
0.99
50
38
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1176
7450
1.77
52.12
2.4
2.1
u/l
285.0
234.6
0.90
1086
6901
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1551
10864
1.65
45.93
2.6
2.2
pmol/l
88.6
91.4
1.56
882
5605
(3031040) Bacteria [#/volume] in Urine by Automated count
2040
15543
1.60
41.05
7.5
5.7
e6/l
3917.8
2032.7
0.39
47
287
(3015377) Calcium [Moles/volume] in Serum or Plasma
1215
8192
1.64
40.53
2.5
3.2
mmol/l
2.3
2.3
0.68
992
6775
(3024561) Albumin [Mass/volume] in Serum or Plasma
1534
10962
1.60
40.25
4.4
4.3
g/l
33.3
33.5
0.52
1333
9923
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
826
5092
1.73
38.33
3.1
3.1
mmol/l
2.5
2.5
0.35
662
4266
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1235
8572
1.59
35.48
2.2
2.2
nmol/l
75.6
81.0
8.29
1034
7217
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1680
12606
1.53
33.44
6.3
6.4
mmol/l
1.2
1.2
1.87
1368
10453
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
808
5122
1.67
33.18
2.0
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
845
5493
1.63
31.17
5.2
4.6
ng/l
138.3
507.5
1.65
772
5009
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
400
2099
1.94
30.91
1.7
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
588
3557
1.71
28.33
2.0
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1935
15265
1.47
28.25
6.6
5.1
—
—
—
0
0
(3026782) Osmolality of Urine
850
5656
1.59
28.04
3.8
3.0
mosm/kgh2o
572.0
541.6
4.41
715
4794
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
337
1751
1.95
26.69
1.6
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1495
11349
1.46
25.85
5.4
5.7
mmol/l
1.2
1.2
0.61
1322
10075
(3003338) MCHC [Mass/volume]
1881
14956
1.44
25.08
34.2
27.4
g/l
328.7
329.6
3.53
1800
14651
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
98
300
3.21
24.59
1.4
1.3
mg/l
840.5
573.8
0.48
91
284
(3013826) Glucose [Moles/volume] in Serum or Plasma
1762
13877
1.43
24.56
5.4
4.7
mmol/l
7.3
7.0
5.29
1641
13030
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
577
3602
1.65
24.39
2.0
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
827
5626
1.54
24.26
1.8
1.8
pmol/l
430.5
6763283.6
1.28
657
4436
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1095
7943
1.47
23.41
2.8
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1109
8072
1.47
23.27
4.4
3.6
e6/l
88.1
148.0
1.42
873
6373
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
88
261
3.31
23.26
1.3
1.3
mmol/l
4.3
4.0
1.39
82
233
(3002032) Base excess in Venous blood by calculation
484
2949
1.67
22.35
3.6
3.3
mmol/l
1.8
2.0
0.44
395
2319
(3039000) Anion gap in Blood
140
548
2.53
22.33
4.6
5.4
mmol/l
11.4
11.3
0.09
127
483
(3018572) Chloride [Moles/volume] in Blood
140
548
2.53
22.33
4.6
5.4
mmol/l
104.7
104.6
0.04
127
483
(3024354) Oxygen [Partial pressure] in Venous blood
417
2442
1.73
22.29
3.4
2.9
kpa
4.2
4.3
0.37
391
2327
(3047181) Lactate [Moles/volume] in Blood
179
792
2.24
21.70
4.7
4.9
mmol/l
1.3
1.4
0.38
159
692
(3021447) Carbon dioxide [Partial pressure] in Venous blood
481
2957
1.66
21.41
3.6
3.3
kpa
5.8
5.8
0.27
456
2834
(3018095) Leukocytes [#/volume] in Urine
1193
8934
1.43
21.04
5.1
4.1
e6/l
264.5
150.4
1.02
885
6732
(3007930) Methemoglobin/Hemoglobin.total in Blood
237
1197
1.98
20.30
4.4
4.2
%
0.9
0.9
2.56
224
1122
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
83
259
3.14
20.23
1.4
1.4
e6/l
3.7
45.7
1.18
64
210
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
83
260
3.13
20.10
1.6
1.4
e6/l
1085.1
1063.2
0.01
66
216
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
193
919
2.09
19.45
2.0
1.5
%
1.7
1.6
0.20
147
722
(3018418) pH of Serum or Plasma
1019
7502
1.43
19.43
3.4
3.8
ph
7.4
7.4
0.25
163
1413
(3044290) Cell count panel - Cerebral spinal fluid
76
231
3.22
19.36
1.3
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1036
7657
1.43
19.31
2.5
2.4
mg/l
3.2
3.3
0.31
835
6396
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
236
1211
1.94
19.31
4.3
4.1
%
1.6
1.5
1.12
223
1138
(3021960) Folate [Moles/volume] in Serum or Plasma
927
6716
1.44
19.26
1.8
1.7
nmol/l
18.0
19.6
2.13
830
5649
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2339
19786
1.38
19.20
27.8
20.4
mg/l
30.6
30.0
0.38
2130
16904
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
200
970
2.05
19.19
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
174
801
2.15
19.15
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
174
801
2.15
19.15
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1994
16464
1.37
18.89
30.0
22.3
%
35.1
36.5
4.47
1067
9238
(3023183) Ammonium ion [Moles/volume] in Plasma
113
433
2.57
18.88
1.5
1.9
umol/l
27.2
32.7
1.40
82
332
(40768804) Tissue Pathology biopsy report
598
8041
0.66
18.02
2.0
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1431
11343
1.36
16.97
13.7
12.9
inr
1.5
1.5
0.20
329
2994
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1360
10717
1.36
16.68
3.5
3.0
u/l
61.1
58.8
0.32
1190
9493
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1507
12100
1.34
16.19
4.3
5.5
umol/l
12.8
13.2
0.43
1389
11385
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
619
4275
1.48
16.17
3.8
3.3
e6/l
3.2
2.2
0.97
338
2476
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
285
4417
0.59
15.94
1.5
1.6
mmol/l
1.3
1.2
0.49
255
3608
(3033705) Calcium.ionized [Moles/volume] in Venous blood
120
513
2.30
15.85
3.1
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
121
520
2.29
15.79
3.1
2.5
mmol/l
4.2
4.2
0.04
121
514
(3035285) Chloride [Moles/volume] in Venous blood
121
520
2.29
15.79
3.1
2.5
mmol/l
106.1
105.4
0.56
121
514
(3024891) Influenza virus A+B Ag [Presence] in Specimen
130
576
2.22
15.77
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1309
10370
1.34
15.09
5.4
4.8
ng/l
178.5
68.5
0.39
1028
8444
(36304419) Bacteria [Presence] in Urine
929
6980
1.38
15.07
4.3
3.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2063
17440
1.32
15.05
4.9
4.7
mu/l
2.0
2.1
3.44
1820
15233
(3030467) Casts [#/volume] in Urine by Automated count
967
7345
1.37
14.59
4.3
3.6
e6/l
0.5
0.6
0.17
765
5737
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
240
1408
1.69
12.64
2.7
3.2
mmol/l
23.9
24.1
0.37
219
1251
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
926
7121
1.34
12.58
2.6
2.4
u/l
55.5
60.0
1.58
854
6501
(3015736) pH of Urine
1067
8378
1.32
12.55
5.3
4.2
—
5.9
—
0
9
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
241
1419
1.69
12.52
2.8
2.4
%
1.1
1.1
0.23
241
1411
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
459
3137
1.47
12.45
4.0
3.3
ng/l
367.4
339.6
0.49
427
2848
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1961
16732
1.28
12.07
6.6
7.2
u/l
85.0
85.4
0.10
1793
15466
(3014271) Vancomycin [Susceptibility]
63
227
2.71
12.02
3.5
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
770
5797
1.36
11.95
3.4
2.8
e6/l
5.4
4.9
0.69
682
5090
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
774
5838
1.35
11.86
2.9
2.8
u/l
37.6
36.6
0.14
699
5428
(3019550) Sodium [Moles/volume] in Serum or Plasma
2361
20673
1.28
11.56
32.4
25.0
mmol/l
139.3
139.2
0.65
2252
19970
(3023103) Potassium [Moles/volume] in Serum or Plasma
2362
20693
1.28
11.46
32.5
25.2
mmol/l
4.0
4.0
6.10
2242
19960
(3036481) Cortisol [Moles/volume] in Serum or Plasma
264
1635
1.60
11.24
1.8
1.9
nmol/l
394.2
392.5
0.04
232
1449
(3010813) Leukocytes [#/volume] in Blood
2368
20820
1.27
10.79
36.6
29.7
e9/l
7.6
7.2
5.82
2231
19867
(3000963) Hemoglobin [Mass/volume] in Blood
2368
20820
1.27
10.79
36.9
29.9
g/l
124.9
128.3
22.59
2265
20237
(3007461) Platelets [#/volume] in Blood
2367
20812
1.27
10.78
36.7
29.7
e9/l
233.5
232.2
0.36
2243
19965
(3035941) MCH [Entitic mass]
2367
20814
1.27
10.76
36.5
29.6
pg
30.3
30.4
2.18
2260
20208
(3026361) Erythrocytes [#/volume] in Blood
2367
20815
1.27
10.75
36.6
29.7
e12/l
4.2
4.3
14.20
2221
19868
(3024731) MCV [Entitic volume]
2367
20815
1.27
10.75
36.5
29.6
fl
91.9
92.1
1.08
2259
20212
(3008152) Bicarbonate [Moles/volume] in Arterial blood
283
1806
1.56
10.60
5.3
5.7
mmol/l
24.9
24.5
1.00
265
1689
(3018677) aPTT in Platelet poor plasma by Coagulation assay
569
4155
1.38
10.59
1.7
1.8
s
30.1
30.6
1.00
549
3996
(3038515) Glucose [Moles/volume] in Venous blood
146
786
1.83
10.40
5.0
3.7
mmol/l
8.1
8.0
0.19
146
776
(3052592) Norovirus Ag [Presence] in Stool
25
54
4.50
10.39
1.4
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
173
980
1.74
10.38
7.5
5.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
470
3336
1.41
10.32
4.5
5.4
mmol/l
1.7
1.1
2.31
348
2503
(3007853) Bacteria identified in Skin by Aerobe culture
411
2850
1.44
10.27
1.8
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
606
4509
1.36
9.98
3.6
3.1
e6/l
1.3
1.4
0.37
324
2689
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1662
14099
1.25
9.95
3.6
3.8
pmol/l
15.2
15.3
0.78
1441
12252
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
466
3340
1.40
9.65
4.5
5.4
kpa
5.0
5.0
0.07
416
3097
(3008037) Lactate [Moles/volume] in Venous blood
148
819
1.78
9.65
4.9
3.6
mmol/l
1.6
1.7
1.14
148
810
(3027801) Oxygen [Partial pressure] in Arterial blood
466
3341
1.40
9.64
4.5
5.4
kpa
10.8
11.4
1.76
413
3093
(3002385) Erythrocyte distribution width [Ratio]
1761
15094
1.24
9.41
32.4
24.8
%
14.4
14.2
6.01
1683
14613
(4035726)
107
1884
0.54
9.39
1.2
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1264
10450
1.26
9.31
5.7
4.4
estimate
0.0
0.0
0.00
188
1975
(3009261) Glucose [Presence] in Urine by Test strip
1271
10580
1.24
8.65
6.0
4.5
estimate
0.0
0.0
0.00
184
1941
(3027273) Bicarbonate [Moles/volume] in Venous blood
248
1615
1.52
8.50
4.4
3.4
mmol/l
25.6
25.0
2.04
240
1564
(3019060) Gas panel - Arterial blood
295
1993
1.47
8.44
3.8
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2222
19651
1.23
8.41
25.9
19.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
134
2.83
8.23
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
33
103
3.11
8.22
1.4
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
732
5756
1.28
7.99
3.5
3.9
%
75.8
78.1
1.60
705
5599
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
353
2491
1.41
7.98
2.1
2.4
umol/l
10.7
10.8
0.02
273
2142
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
25
67
3.62
7.88
2.5
2.0
umol/l
59.4
56.0
0.20
18
48
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
68
310
2.14
7.87
4.9
5.4
mg/l
13.3
12.8
0.32
59
272
(3022217) INR in Platelet poor plasma by Coagulation assay
621
4789
1.30
7.85
32.9
34.5
inr
1.8
1.6
1.04
87
611
(3021601) Nitrite [Presence] in Urine by Test strip
1245
10428
1.23
7.81
8.5
6.1
estimate
0.0
0.0
0.00
188
1948
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
213
1371
1.53
7.73
6.2
7.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
163
998
1.60
7.36
2.3
2.1
ug/l
1135.4
560.1
0.66
143
946
(3024928) Oxygen saturation in Venous blood
104
570
1.78
7.10
1.6
2.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
307
2160
1.41
7.07
3.1
3.4
ng/l
103.7
103.8
0.01
230
1785
(3002256) Pathology report gross observation
198
2791
0.67
7.04
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
327
0.21
6.88
1.4
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
394
2917
1.34
6.62
4.9
5.7
%
94.2
95.0
0.95
364
2779
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
156
2275
0.65
6.55
1.2
1.2
u/ml
4.7
16.7
2.87
33
725
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
41
164
2.43
6.49
2.8
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
373
2756
1.34
6.35
5.1
4.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
517
4000
1.29
6.31
2.1
2.5
mmol/l
0.8
0.8
0.24
434
3613
(3012516) Albumin [Mass/volume] in Urine
601
7036
0.79
6.28
3.0
3.2
mg/l
839.7
274.8
1.42
422
4586
(3027945) Reticulocytes/100 erythrocytes in Blood
504
3890
1.29
6.27
2.1
2.2
%
1.7
1.8
0.13
394
3336
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
285
2028
1.39
6.16
1.9
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
340
4274
0.75
6.15
3.8
3.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
21
60
3.39
6.07
3.0
2.8
umol/l
29.7
29.2
0.06
13
43
(3009508) Creatinine [Moles/volume] in Urine
604
7041
0.80
6.06
2.8
3.1
mmol/l
6.7
6.6
0.43
471
5588
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
194
1298
1.47
5.90
1.9
1.8
ug/l
3.1
2.3
0.38
146
1088
(3002030) Lymphocytes/100 leukocytes in Blood
1188
10126
1.20
5.84
5.1
5.4
%
22.7
23.9
2.61
1055
9178
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
383
2889
1.31
5.65
2.5
2.6
ug/l
4.4
5.8
2.29
266
2381
(3013707) Erythrocyte sedimentation rate by Westergren method
1720
15175
1.18
5.58
3.9
4.2
mm/h
18.3
17.1
1.67
1516
13660
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
19
54
3.41
5.55
1.3
1.2
%
—
55.9
—
0
8
(3041096) Erythrocytes [Presence] in Urine by Automated
660
5338
1.24
5.50
6.6
4.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
344
2567
1.32
5.49
5.3
6.1
g/l
118.8
117.9
0.36
331
2474
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
286
2077
1.36
5.47
2.3
2.4
u/l
28.9
35.6
2.80
236
1738
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
1093
0.55
5.38
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
62
317
1.90
5.36
2.0
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
324
2408
1.33
5.32
4.6
6.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
62
319
1.89
5.27
2.8
2.3
u/field
4.2
2.3
0.67
20
93
(3044640) Blood type and Crossmatch panel - Blood
897
7512
1.20
5.25
2.3
2.7
—
—
—
0
0
(4010399)
86
1358
0.60
5.17
1.3
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1156
9920
1.18
5.12
5.0
5.2
%
61.8
60.5
2.70
1037
9055
(3022096) Basophils/100 leukocytes in Blood
1132
9702
1.18
5.08
4.5
5.1
%
0.5
0.6
1.77
1020
8846
(3003458) Phosphate [Moles/volume] in Serum or Plasma
461
3611
1.27
5.08
4.4
4.6
mmol/l
1.0
1.1
0.12
388
3248
(3028707) Methadone [Presence] in Urine by Screen method
10
18
5.38
5.08
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
183
2461
0.70
5.07
1.2
1.2
iu/ml
46.1
42.3
0.11
58
752
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
45
210
2.08
5.04
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1064
9084
1.18
4.98
3.0
2.9
ug/l
135.4
156.6
2.49
923
8059
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
45
212
2.06
4.92
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
36
155
2.26
4.92
3.3
1.9
u/field
2.0
2.4
0.20
20
98
(3052851) Hemolysis interference index of Serum or Plasma
136
882
1.51
4.88
4.7
3.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
215
1521
1.39
4.87
7.0
4.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
216
1536
1.38
4.75
3.7
2.9
e6/l
0.3
0.4
0.89
210
1512
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
170
1161
1.43
4.71
2.0
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
116
2.43
4.67
1.4
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1156
9984
1.17
4.65
5.2
5.5
%
8.9
9.1
1.02
1038
9106
(3006504) Eosinophils/100 leukocytes in Blood
1151
9941
1.17
4.62
4.8
5.2
%
2.8
2.8
0.02
1031
9054
(3006653) Thiamine [Moles/volume] in Blood
22
77
2.77
4.60
1.0
1.0
nmol/l
124.1
136.2
0.71
22
77
(3020682) Albumin/Creatinine [Ratio] in Urine
673
7557
0.83
4.54
3.5
3.9
mg/mmol
15.7
10.6
1.44
445
4858
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
935
7950
1.18
4.53
7.0
5.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2222
20185
1.16
4.51
10.4
11.1
u/l
22.7
22.9
0.09
2077
19056
(3014576) Chloride [Moles/volume] in Serum or Plasma
440
3481
1.25
4.46
5.0
5.6
mmol/l
104.6
104.1
1.06
427
3398
(3014111) Lactate [Moles/volume] in Serum or Plasma
328
2507
1.29
4.42
3.9
5.1
mmol/l
1.6
1.5
0.78
305
2346
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
182
1275
1.40
4.39
2.0
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
577
4710
1.22
4.35
6.4
5.0
kg/l
1.0
1.0
0.29
115
800
(3013650) Neutrophils [#/volume] in Blood by Automated count
1379
12135
1.16
4.26
5.8
7.5
e9/l
5.0
4.6
5.00
1109
10294
(3019198) Lymphocytes [#/volume] in Blood
1217
10614
1.16
4.24
4.7
5.0
e9/l
1.8
1.8
0.10
982
8983
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
14
39
3.48
4.24
6.5
2.7
u/field
0.3
0.4
0.41
14
39
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
290
2194
1.30
4.23
1.6
1.9
g/l
0.2
0.2
2.48
246
1981
(3008116) Ketones [Moles/volume] in Urine by Test strip
15
45
3.23
4.07
1.4
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
569
4680
1.21
3.96
2.3
2.4
umol/l
10.3
11.2
2.63
492
4234
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
211
2663
0.75
3.94
4.1
4.8
%
34.8
34.5
0.15
136
1675
(40757373) Influenza virus identified in Isolate
19
69
2.67
3.75
1.4
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1192
10461
1.15
3.71
4.5
4.9
e9/l
0.0
0.0
0.15
967
8694
(3045142) Bone marrow Pathology biopsy report
9
260
0.33
3.68
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
120
1636
0.70
3.67
2.7
3.6
%
1.1
0.6
0.49
22
395
(3008295) Osmolality of Serum or Plasma
47
251
1.82
3.67
1.5
1.3
mosm/kgh2o
282.5
273.7
0.92
26
169
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
122
827
1.44
3.60
2.5
2.8
pmol/l
4.2
4.2
0.19
88
697
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
23
94
2.37
3.60
1.1
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
870
7478
1.16
3.59
4.0
4.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1221
10753
1.14
3.59
4.6
5.0
e9/l
0.2
0.2
0.23
989
9052
(3003181) Sodium [Moles/volume] in Urine
92
592
1.51
3.53
1.4
1.3
mmol/l
57.0
59.6
0.30
74
471
(3001604) Monocytes [#/volume] in Blood
1180
10381
1.14
3.51
4.4
4.9
e9/l
0.7
0.6
2.20
953
8606
(3011648) Oxygen content in Venous blood
34
166
1.99
3.47
1.5
1.4
%
9.6
10.0
0.22
34
166
(3000492) Spirometry study
95
1337
0.68
3.47
1.6
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
22
90
2.37
3.44
1.2
1.2
promille
0.9
1.2
0.43
16
69
(40768797) Stomach Pathology biopsy report
219
2692
0.77
3.39
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
156
1.99
3.29
1.3
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
589
0.54
3.24
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
69
2.53
3.23
1.6
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
189
1404
1.32
3.22
1.4
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
135
1761
0.73
3.20
2.7
3.6
%
0.1
0.1
0.23
37
545
(3019832) Treponema pallidum Ab [Presence] in Serum
57
336
1.65
3.19
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
65
2.53
3.08
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
525
4387
1.18
3.07
2.3
2.4
g/l
2.2
2.2
1.85
456
3973
(4281824)
7
206
0.33
3.06
1.4
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
102
1377
0.71
3.00
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
44
2.86
2.94
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
146
1854
0.75
2.91
2.7
3.6
%
1.3
0.9
0.55
41
591
(3025159) Blasts/100 leukocytes in Blood
122
1590
0.73
2.90
2.6
3.7
%
0.2
0.3
0.24
27
435
(3016038) Potassium [Moles/volume] in Urine
38
206
1.79
2.89
1.1
1.2
mmol/l
33.9
34.7
0.07
27
168
(3013139) Helicobacter pylori Ag [Presence] in Stool
78
1095
0.68
2.87
1.1
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
62
385
1.57
2.85
10.7
10.5
mmol/l
6.8
7.3
0.91
49
314
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
496
4151
1.18
2.85
2.4
2.5
%
19.3
20.3
0.94
361
3473
(3011397) Hemoglobin [Presence] in Urine by Test strip
606
5157
1.16
2.82
4.9
4.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
160
1186
1.32
2.81
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
40
2.90
2.79
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
1358
0.72
2.79
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
35
3.04
2.76
1.4
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
428
3550
1.19
2.74
2.2
1.9
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
45
261
1.67
2.73
1.4
1.3
nmol/l
277.2
304.4
0.35
30
193
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
41
2.83
2.68
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
76
2.29
2.68
1.2
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
192
0.35
2.66
1.9
3.2
u/ml
16.1
48.5
—
7
186
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
42
2.77
2.58
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
161
1981
0.78
2.57
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
144
1067
1.32
2.56
3.8
3.1
nmol/l
0.8
0.8
0.49
107
818
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
220
0.39
2.54
1.8
2.7
nmol/l
14.2
11.0
—
9
211
(3045414) Leukocytes [Presence] in Urine
61
874
0.67
2.53
2.9
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
37
2.88
2.53
1.4
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
37
2.88
2.53
1.4
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
37
2.88
2.53
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
166
1257
1.29
2.52
2.3
2.4
u/ml
0.3
0.4
0.83
85
752
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
252
2937
0.82
2.50
2.4
3.6
ug/l
13.5
22.4
0.42
207
2470
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
43
2.70
2.48
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
43
2.70
2.48
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
30
160
1.82
2.45
4.2
3.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
100
708
1.37
2.42
1.2
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
48
706
0.65
2.30
2.6
3.4
u/ml
113.0
112.8
0.00
48
672
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
22
3.52
2.28
1.4
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
5
151
0.32
2.27
1.0
1.1
—
54.9
—
0
6
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
76
2.17
2.25
1.2
1.3
umol/l
122.2
81.2
—
5
46
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
57
0.00
2.25
0.0
1.5
—
1569.6
—
0
5
(3017446) Testosterone [Moles/volume] in Serum or Plasma
87
1140
0.73
2.22
1.9
2.1
nmol/l
8.9
10.1
0.52
68
952
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
131
1.85
2.18
1.4
2.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
11
41
2.60
2.13
2.3
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
139
1055
1.28
2.12
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
82
576
1.38
2.12
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
75
995
0.72
2.09
1.4
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
30
2.90
2.06
1.4
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
46
291
1.53
2.04
2.0
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
80
2.06
2.01
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
88
632
1.35
2.00
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1115
10052
1.10
1.99
4.2
4.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
21
364
0.55
1.99
1.1
1.6
ug/l
16.9
23.2
0.90
21
352
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
20
3.39
1.98
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
81
576
1.37
1.96
1.3
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
112
836
1.30
1.96
2.4
3.3
mmol/l
25.3
24.9
0.37
102
720
(3014051) Protein [Presence] in Urine by Test strip
34
517
0.63
1.94
3.8
2.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
80
571
1.36
1.90
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
32
189
1.64
1.90
1.1
1.1
u/ml
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
10
38
2.55
1.88
3.3
2.4
umol/l
31.2
39.2
—
10
29
(3027944) Amphetamines [Presence] in Urine
10
38
2.55
1.88
1.4
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
22
3.08
1.81
1.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
351
0.58
1.78
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
32
193
1.61
1.77
15.9
18.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
146
0.40
1.76
1.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
6
148
0.39
1.76
1.2
1.0
—
2.5
—
0
26
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
13
249
0.50
1.73
1.8
1.4
pmol/l
82.4
297.0
2.71
13
240
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
72
2.02
1.71
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
84
616
1.32
1.71
1.6
1.5
ug/g
243.5
258.7
0.30
48
391
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1105
10024
1.09
1.70
3.2
3.5
ng/l
2555.7
2580.0
0.05
918
8740
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
17
86
1.91
1.68
2.4
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
17
86
1.91
1.68
2.4
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
159
1265
1.22
1.68
2.3
2.1
g/l
7.9
7.6
0.84
90
881
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
41
2.36
1.63
2.4
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
158
1262
1.22
1.62
2.3
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
17
291
0.56
1.59
3.1
3.7
%
66.4
61.5
—
8
167
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
64
828
0.74
1.59
1.5
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
61
2.06
1.58
1.2
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
90
676
1.29
1.57
4.7
4.6
mmol/l
2.7
3.0
0.40
68
451
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1740
17498
0.93
1.56
3.8
4.6
mmol/l
1.4
1.4
6.66
1505
15238
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
157
1258
1.21
1.56
2.3
2.1
g/l
3.7
3.8
0.29
89
852
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
10
42
2.30
1.56
1.4
1.3
%
—
17.9
—
0
7
(3044941) Cell count panel - Synovial fluid
53
368
1.40
1.54
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
21
336
0.60
1.54
1.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
261
2192
1.16
1.53
2.1
2.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
40
0.00
1.53
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
44
0.00
1.49
0.0
1.6
—
—
—
0
0
(4094501)
27
403
0.64
1.48
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
272
0.57
1.48
1.2
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
308
2625
1.15
1.48
4.8
5.3
mmol/l
12.9
13.3
0.28
270
2427
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
164
0.47
1.46
1.0
1.1
—
—
—
0
0
(4027681)
11
50
2.13
1.45
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
89
1083
0.79
1.42
2.5
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
169
1924
0.84
1.41
1.2
1.3
titre
590.0
511.6
0.20
36
442
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
64
1.97
1.41
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
205
0.52
1.39
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
16
3.02
1.38
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
22
2.64
1.37
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
22
2.64
1.37
1.2
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
156
0.49
1.36
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
152
1235
1.20
1.35
1.4
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
36
0.00
1.34
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
36
0.00
1.34
0.0
1.0
—
—
—
0
0
(44806420)
22
131
1.63
1.33
2.6
2.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
142
1149
1.20
1.32
2.3
2.2
g/l
3.2
3.2
0.11
89
874
(1616796) Gas panel - Central venous blood
92
711
1.26
1.32
3.5
3.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1773
17740
0.93
1.30
3.9
4.6
mmol/l
4.0
4.2
14.96
1541
15644
(3004616) Nuclear Ab [Presence] in Serum
12
212
0.55
1.30
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
359
3846
0.89
1.30
4.1
4.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
315
1.38
1.29
1.3
1.5
iu/l
3.0
4.9
—
9
82
(3042631) Mycobacterium sp identified in Specimen
32
446
0.69
1.29
2.4
2.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
113
897
1.22
1.28
1.9
2.2
g/l
0.1
0.1
0.22
87
798
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
186
1546
1.17
1.28
4.8
6.7
mmol/l
24.7
24.3
0.67
152
1380
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
170
0.51
1.28
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
45
316
1.38
1.27
4.3
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1691
16936
0.94
1.26
3.5
4.1
mmol/l
1.2
1.2
0.20
1446
14575
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
60
1.94
1.26
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
98
768
1.24
1.26
5.1
4.4
ph
7.4
7.4
0.58
87
659
(3023520) Reticulocytes [#/volume] in Blood
333
2888
1.13
1.26
2.3
2.3
e9/l
64.2
66.3
0.55
250
2215
(3032057) Clostridioides difficile [Presence] in Stool
13
68
1.85
1.21
2.8
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
137
0.49
1.20
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
74
565
1.27
1.20
1.6
1.5
e6/l
19138.1
19427.4
0.02
51
402
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
36
246
1.42
1.20
1.8
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
238
1.42
1.19
1.7
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
49
354
1.34
1.18
1.2
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
19
2.54
1.17
1.2
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
11
55
1.93
1.16
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
143
1617
0.85
1.15
1.7
1.8
ug/g
286.8
172.4
1.45
115
1221
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
67
509
1.28
1.14
1.8
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
35
0.00
1.14
0.0
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
20
2.42
1.10
1.4
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
32
2.12
1.05
3.6
8.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
460
0.73
1.05
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
81
955
0.82
1.04
1.9
2.6
u/ml
108.1
4723.4
0.99
66
807
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
221
0.61
1.04
1.4
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
301
2629
1.12
1.04
2.2
2.3
g/l
64.8
65.5
0.75
241
2291
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
437
0.73
1.04
1.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
144
0.54
1.03
1.4
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
58
1.83
1.02
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
1191
1.17
1.01
2.3
2.1
g/l
10.2
10.6
0.31
98
972
(3009343) pH of Capillary blood
216
1855
1.13
1.00
3.2
3.8
ph
7.4
7.4
0.17
27
232
(3003694) ABO and Rh group [Type] in Blood
427
4465
0.91
1.00
1.2
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1917
18014
1.06
0.98
7.0
7.0
mmol/mol
43.9
42.0
8.49
1692
15998
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
30
0.00
0.96
0.0
1.0
—
98.0
—
0
19
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
48
359
1.30
0.95
1.2
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
23
152
1.46
0.94
2.4
3.4
mmol/l
8.4
7.5
0.65
18
100
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
103
841
1.19
0.94
1.9
2.2
g/l
0.0
0.0
0.50
79
746
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
126
1047
1.17
0.94
2.2
2.3
g/l
1.3
1.4
0.04
91
851
(40768441) Liver Pathology biopsy report
6
115
0.50
0.93
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1004
9269
1.06
0.93
4.5
5.8
ug/l
6.2
6.0
0.02
826
8065
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
620
5631
1.08
0.93
2.1
2.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
250
2178
1.12
0.93
3.8
3.7
mmol/l
1.2
1.2
0.13
218
1872
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
36
1.88
0.93
1.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
19
121
1.52
0.92
1.3
1.2
—
3.0
—
0
7
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
154
1695
0.87
0.91
3.7
3.1
ml/min/173m2
57.2
53.5
0.65
63
834
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
12
68
1.71
0.90
1.1
1.0
mg/l
215.3
284.3
1.53
12
58
(3043409) Potassium [Moles/volume] in Arterial blood
104
855
1.18
0.89
3.5
3.6
mmol/l
4.0
3.9
0.81
94
789
(3014891) Appearance of Pleural fluid
13
76
1.65
0.88
1.6
1.5
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
54
1.79
0.87
1.2
1.5
pmol/l
16.3
15.9
—
10
42
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
101
830
1.18
0.87
1.9
2.2
g/l
0.0
0.0
0.00
79
743
(3045424) Erythrocytes [Presence] in Urine
22
301
0.70
0.87
1.5
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
37
271
1.32
0.87
1.6
1.6
u/ml
21.4
27.3
—
10
61
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
131
1.48
0.87
1.6
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
29
2.00
0.86
1.0
1.0
miu/ml
2543.2
1501.8
—
6
29
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
29
2.00
0.86
1.5
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
29
2.00
0.86
1.5
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
345
0.73
0.86
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
584
5310
1.07
0.86
4.7
6.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
30
1.93
0.84
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
242
0.68
0.83
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
511
5255
0.93
0.82
2.9
3.4
ug/l
0.8
0.9
2.19
361
3869
(3022621) pH of Urine by Test strip
189
1635
1.12
0.82
5.8
3.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
490
1.23
0.82
1.5
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
199
1.36
0.81
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
60
705
0.82
0.80
1.6
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
194
1684
1.12
0.80
1.5
1.6
g/l
1.5
1.5
0.09
156
1420
(3028626) Oxygen [Partial pressure] in Capillary blood
90
740
1.18
0.79
2.2
3.0
kpa
7.4
7.6
0.62
83
681
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
23
0.00
0.79
0.0
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
31
225
1.33
0.79
1.8
2.2
ml
691.3
607.8
0.38
19
131
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
25
0.00
0.78
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
32
1.81
0.78
1.5
4.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
58
682
0.82
0.78
1.3
1.2
u/ml
185.6
211.5
0.23
50
608
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.0
—
0.8
—
0
7
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
206
1798
1.11
0.77
3.3
3.7
mmol/l
2.4
2.0
0.55
140
1292
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
95
1.53
0.77
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
180
0.64
0.77
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
112
941
1.15
0.76
2.3
2.7
g/l
0.5
0.3
0.68
34
368
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
27
0.00
0.76
0.0
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
78
638
1.19
0.74
2.3
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
31
389
0.77
0.74
3.8
2.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
41
496
0.80
0.73
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
37
1.83
0.73
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
279
0.73
0.73
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
148
1273
1.13
0.73
3.6
3.4
e9/l
4.3
4.3
0.04
97
825
(3029937) Albumin [Presence] in Urine by Test strip
624
5725
1.06
0.72
6.5
4.9
estimate
0.0
0.0
0.50
160
1813
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
115
973
1.15
0.72
1.9
2.1
g/l
35.9
36.2
0.21
80
788
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
214
1885
1.10
0.70
3.3
3.8
kpa
5.3
5.2
0.74
179
1703
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
56
1.55
0.69
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
75
616
1.18
0.69
4.7
3.9
mg/l
28.8
32.9
0.51
60
427
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
205
1.32
0.69
1.2
1.4
g/l
0.7
1.0
1.30
23
152
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
334
1.25
0.69
1.1
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
42
326
1.25
0.68
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
37
448
0.80
0.68
1.8
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
114
0.59
0.68
1.0
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
123
1.42
0.67
1.3
1.2
g/l
0.3
0.5
1.33
13
89
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
123
1.42
0.67
1.3
1.2
g/l
7.0
7.7
0.26
13
87
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
123
1.42
0.67
1.3
1.2
g/l
2.7
2.8
0.07
13
90
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
800
7414
1.05
0.66
4.3
5.0
%
22.8
22.7
0.04
376
4095
(3011288) Drugs identified in Urine by Screen method
5
27
1.79
0.66
1.2
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
41
319
1.24
0.65
1.3
1.2
nmol/l
0.7
0.8
0.16
31
256
(3004809) Band form neutrophils/100 leukocytes in Blood
39
466
0.81
0.64
2.9
3.8
%
1.5
1.5
0.01
25
335
(3017704) Immunofixation for Urine
24
174
1.33
0.64
1.1
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
28
1.73
0.64
2.8
8.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
84
1.50
0.63
2.1
2.6
%
35.2
34.3
—
6
34
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
777
1.15
0.62
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
126
1087
1.12
0.62
2.0
2.8
ratio
1.7
3.6
—
7
81
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
48
1.61
0.61
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
282
2926
0.93
0.61
14.7
10.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
19
0.00
0.60
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(4062490)
18
126
1.38
0.60
1.3
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
21
0.00
0.59
0.0
1.1
—
1.7
—
0
21
(3035637) Corticotropin [Mass/volume] in Plasma
24
177
1.31
0.59
1.2
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
98
836
1.14
0.58
2.0
2.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
51
1.52
0.58
3.0
2.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
128
1111
1.12
0.58
2.0
2.8
mg/l
61.6
117.8
0.56
102
907
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
20
256
0.75
0.58
1.1
1.2
—
42.1
—
0
25
(3017569) Oxygen content in Arterial blood
13
178
0.70
0.57
1.5
2.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
397
1.20
0.56
1.2
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
85
0.57
0.56
1.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
15
103
1.41
0.56
2.5
3.9
%
54.8
55.7
0.06
15
93
(1002224) Polysomnography panel
18
232
0.75
0.55
1.0
1.1
—
—
—
0
0
(44806118)
28
214
1.27
0.54
1.2
1.4
—
—
—
0
0
(44790049)
28
214
1.27
0.54
1.2
1.4
—
—
—
0
0
(44790048)
28
214
1.27
0.54
1.2
1.4
—
—
—
0
0
(44790047)
28
214
1.27
0.54
1.2
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
165
0.70
0.54
1.2
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
37
1.57
0.54
2.0
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
317
0.79
0.54
1.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
329
1.21
0.52
1.2
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
128
0.68
0.52
1.6
1.5
%
11.0
17.8
—
9
110
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
130
1.34
0.51
1.6
1.6
u/l
3.6
8.8
1.43
11
64
(4211845)
9
131
0.66
0.51
4.7
4.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
292
0.79
0.50
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
22
165
1.29
0.50
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
61
677
0.87
0.49
1.1
1.1
iu/ml
63.9
101.7
0.63
14
211
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
491
4536
1.05
0.49
1.7
1.6
mg/l
1.5
1.7
0.96
394
3547
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
65
1.49
0.48
1.1
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
126
1109
1.10
0.47
2.0
2.8
mg/l
52.9
62.3
0.20
99
911
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
81
0.60
0.45
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
142
1.29
0.45
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
142
1.29
0.45
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
49
1.38
0.44
1.4
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
31
360
0.83
0.44
1.3
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
30
1.61
0.43
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
43
356
1.17
0.42
3.2
3.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
84
1.38
0.42
1.4
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
84
1.38
0.42
1.4
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
81
703
1.12
0.41
2.0
2.4
g/l
124.9
122.9
0.24
65
504
(3025941) Bacteria identified in Stool by Culture
114
1008
1.10
0.41
1.4
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
33
1.46
0.40
1.0
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
46
511
0.87
0.40
1.3
1.4
e6/l
104624.7
75362.3
0.18
30
307
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
215
1.21
0.40
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
339
3124
1.05
0.39
1.2
1.2
u/ml
2.8
1.5
0.49
63
730
(4268621)
7
100
0.68
0.39
1.9
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1885
18472
0.97
0.39
4.5
5.3
mmol/l
2.2
2.4
16.73
1670
16196
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
33
269
1.19
0.39
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
34
278
1.18
0.39
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
34
1.42
0.39
1.2
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
165
0.76
0.39
1.2
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
64
1.36
0.38
1.2
3.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
181
1.23
0.38
1.1
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
142
1274
1.08
0.38
2.3
2.6
g/l
11.3
11.1
0.15
122
1135
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1952
18605
1.03
0.37
4.6
5.3
mmol/l
6.3
6.2
2.95
1669
16082
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
164
0.76
0.37
1.2
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
13
164
0.76
0.37
1.2
1.1
—
43.8
—
0
9
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
66
1.32
0.37
1.4
1.2
iu/ml
258.6
223.1
—
9
66
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
301
0.83
0.37
2.7
4.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
111
0.70
0.37
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
11
78
1.36
0.36
4.5
5.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
29
236
1.19
0.36
1.2
1.4
titre
503.3
250.4
—
6
25
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
173
1569
1.07
0.35
2.6
2.6
—
—
—
0
0
(3020891) Body temperature
109
1141
0.92
0.35
5.0
4.1
—
—
—
0
0
(44813793)
5
78
0.62
0.35
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
192
1.21
0.35
1.1
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
121
0.72
0.35
4.7
4.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
122
0.71
0.35
1.0
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
163
1677
0.94
0.34
6.0
7.0
%
91.4
93.7
1.91
163
1667
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
10
129
0.75
0.34
1.2
1.1
—
134.0
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
256
0.83
0.34
1.3
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
42
462
0.88
0.33
1.4
1.6
mg/l
16.5
13.8
0.74
37
415
(3033799) Differential panel - Peritoneal fluid
6
85
0.68
0.33
1.7
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
55
593
0.89
0.33
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
45
1.29
0.32
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
221
1.18
0.32
1.0
1.0
—
—
—
0
0
(3013512) EKG study
739
7321
0.97
0.32
5.6
4.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
42
357
1.14
0.32
1.0
1.1
—
22.8
—
0
13
(3045788) Cell count panel - Pleural fluid
39
429
0.88
0.32
1.5
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
89
1.30
0.31
1.7
1.7
%
17.6
18.4
—
7
35
(3024522) Salmonella sp identified in Specimen by Organism specific culture
33
276
1.16
0.31
1.3
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
51
1.33
0.31
1.3
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
902
8898
0.97
0.30
10.5
10.8
e9/l
0.0
0.0
0.36
671
7079
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
342
1.13
0.29
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
54
471
1.11
0.28
1.3
1.2
—
106.0
—
0
10
(4146454)
25
281
0.86
0.28
1.9
2.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
370
3457
1.04
0.27
2.8
3.4
u/l
245.6
254.1
0.59
324
3198
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
63
1.23
0.27
1.4
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
155
0.81
0.26
1.9
3.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
72
0.67
0.26
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
72
0.67
0.26
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
209
2109
0.95
0.25
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
191
1.16
0.25
1.2
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
36
1.34
0.23
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
46
404
1.10
0.23
1.7
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
10
76
1.27
0.23
1.2
1.7
mmol/l
0.7
0.8
—
10
69
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
193
0.85
0.22
1.1
1.2
pmol/l
264.1
237.3
0.11
12
148
(4212803)
5
39
1.24
0.22
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
32
276
1.12
0.22
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
264
0.88
0.21
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
50
443
1.09
0.21
1.5
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
202
0.86
0.21
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
32
277
1.12
0.21
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
13
0.00
0.20
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
13
0.00
0.20
0.0
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
13
0.00
0.20
0.0
1.9
—
6.5
—
0
8
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
13
0.00
0.20
0.0
1.1
—
1.4
—
0
6
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
34
296
1.11
0.20
2.1
2.8
—
—
—
0
0
(3019225) pH of Specimen
276
2584
1.03
0.20
5.3
4.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
142
1311
1.05
0.20
3.4
3.9
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
1.1
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
14
0.00
0.20
0.0
1.4
—
0.5
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
14
160
0.84
0.20
3.3
2.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
32
278
1.11
0.20
1.3
1.3
—
—
—
0
0
(4034850)
69
623
1.07
0.20
15.7
13.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
282
0.89
0.19
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
50
1.16
0.19
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
51
1.14
0.18
1.2
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
112
1031
1.05
0.18
1.3
1.8
g/l
1.1
1.5
1.61
97
904
(3044242) Glucose [Moles/volume] in Arterial blood
16
179
0.86
0.18
1.4
2.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
617
6068
0.98
0.18
2.6
3.0
umol/l
4070.6
8704.5
2.03
492
4950
(4306422)
10
117
0.83
0.18
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
188
1.13
0.17
1.6
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
88
1.21
0.17
1.6
1.3
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
7
60
1.13
0.17
1.3
2.6
ml/dl
13.5
14.3
—
7
55
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
70
637
1.06
0.17
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
64
0.75
0.17
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
107
1.17
0.16
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
76
0.76
0.15
2.7
1.9
—
—
—
0
0
(3036603) Volume of Urine
10
115
0.84
0.15
1.2
1.4
ml
1547.4
1669.6
—
5
45
(3023419) Bacteria identified in Sputum by Culture
33
346
0.92
0.14
1.7
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
83
0.81
0.14
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
85
0.80
0.14
2.3
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
85
0.80
0.14
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1848
17738
1.01
0.14
25.7
20.1
ml/min/173m2
64.3
64.2
0.03
1500
14857
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
145
1.13
0.14
1.1
1.1
u/ml
1.8
5.0
—
5
73
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
90
1.18
0.14
1.7
1.8
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
11
124
0.86
0.14
1.2
1.3
mmol/l
2.4
3.4
1.73
11
109
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
64
586
1.06
0.14
1.2
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
1506
14442
1.01
0.13
4.6
4.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
142
1328
1.03
0.13
2.7
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
79
798
0.96
0.13
1.6
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
133
0.87
0.12
1.4
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
119
1.14
0.12
1.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
119
1.14
0.12
1.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
119
1.14
0.12
1.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
119
1.14
0.12
1.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
54
550
0.95
0.12
1.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
147
1.12
0.12
1.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
122
0.87
0.11
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
54
549
0.95
0.11
1.2
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
21
185
1.10
0.11
2.7
3.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
64
646
0.96
0.10
1.8
2.3
ug/min
296.8
99.8
0.77
31
381
(40761535) Cells panel - Urine sediment
229
2167
1.02
0.10
4.3
3.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
44
448
0.95
0.10
1.3
1.2
u/l
26.4
55.2
1.51
37
383
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
44
1.10
0.09
1.6
1.6
ng/l
88.4
122.8
—
5
44
(3012441) Differential panel - Pleural fluid
52
480
1.05
0.09
1.3
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
96
899
1.03
0.09
2.3
2.5
—
15.9
—
0
17
(3023199) Leukocytes [#/volume] in Pleural fluid
54
545
0.96
0.09
1.3
1.5
e6/l
2790.2
1407.2
0.48
35
396
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
55
1.05
0.08
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
43
396
1.05
0.08
2.1
2.3
mg/l
34.7
26.1
0.32
16
87
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
60
558
1.04
0.08
1.7
2.5
mg/l
2.0
1.9
0.17
48
476
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
62
0.78
0.08
1.0
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
208
0.93
0.08
1.1
1.3
u/ml
119.3
119.0
—
6
37
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
198
1.07
0.08
1.0
1.1
u/ml
342.0
330.5
0.04
11
114
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
217
1.07
0.07
1.3
1.2
e6/l
26303.2
205480.8
2.09
11
149
(40768806) Pleura Pathology biopsy report
48
483
0.96
0.07
1.4
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
178
0.92
0.07
1.9
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
74
1.04
0.07
1.0
1.3
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
8
76
1.02
0.07
1.4
1.6
ug/l
107.3
107.6
—
8
66
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
80
0.85
0.07
1.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
7
80
0.85
0.07
1.3
1.6
e9/l
0.1
0.6
—
7
74
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
218
1.06
0.07
1.2
1.1
u/l
63.2
56.2
0.27
19
137
(3000012) Reticulocyte production index
18
187
0.93
0.06
1.7
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
87
0.89
0.06
2.3
3.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
71
706
0.97
0.06
1.4
1.6
u/l
34.0
37.5
0.73
58
579
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
245
0.95
0.06
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
186
0.93
0.06
1.1
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
186
0.93
0.06
1.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
186
0.93
0.06
1.1
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
191
1871
0.99
0.05
6.3
4.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
67
664
0.97
0.05
2.8
2.6
%
15.6
15.2
0.31
32
346
(3003434) Protein [Mass/volume] in Pleural fluid
63
624
0.97
0.05
1.3
1.5
g/l
28.3
29.5
0.37
55
538
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
51
480
1.03
0.04
1.3
1.5
iu/ml
12.6
14.9
0.06
21
126
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
212
1.05
0.04
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
41
408
0.97
0.04
3.5
3.2
%
64.1
61.5
0.55
41
408
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
184
1.05
0.03
1.2
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
111
1087
0.99
0.03
4.1
4.2
mmol/l
25.0
24.7
0.37
82
975
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
173
0.95
0.03
1.2
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
17
173
0.95
0.03
1.4
1.5
%
79.2
69.0
—
9
136
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
173
0.95
0.03
1.2
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
12
108
1.07
0.03
1.1
1.1
u/l
32.3
38.5
—
7
84
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
192
0.96
0.02
1.1
1.3
nmol/l
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
32
300
1.03
0.02
1.4
1.9
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
15
137
1.06
0.02
1.1
1.2
—
31.9
—
0
7
(3029634) Reagin Ab [Titer] in Serum by VDRL
13
132
0.95
0.01
2.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
17
158
1.04
0.01
1.4
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
48
457
1.01
0.01
1.3
1.3
g/l
1.2
1.1
0.60
42
426
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
325
0.98
0.01
1.2
1.3
—
—
—
0
0
(4024509)
26
257
0.98
0.00
1.3
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32
315
0.98
0.00
4.0
3.5
iu/ml
693.4
942.6
—
7
37
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
207
1.03
0.00
1.5
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
10
93
1.04
0.00
1.2
1.1
g/l
37.4
40.1
—
5
40
(3048879) Bone marrow aspiration report
10
93
1.04
0.00
1.3
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
46
447
0.99
0.00
1.3
1.3
g/l
0.3
0.2
1.13
40
419
(3035880) pH of Pleural fluid
25
238
1.01
0.00
1.1
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
24
229
1.01
0.00
1.5
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
291
2807
1.00
0.00
1.4
1.4
g/l
3.3
2.8
1.07
146
1526
(3024263) Appearance of Synovial fluid
14
132
1.02
0.00
1.6
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
279
1.00
0.00
1.5
1.4
%
67.1
67.8
0.04
22
183
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
197
0.98
0.00
1.6
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
54
0.89
0.00
1.8
1.3
g/l
20.3
31.1
—
5
41
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
92
0.94
0.00
1.1
1.5
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
280.2
—
0
6
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
9.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
64
0.91
0.00
1.0
1.1
—
37.0
—
0
7
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
49
0.99
0.00
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.4
—
14.5
—
0
8
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
2.2
—
1.1
—
0
9
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
78
0.99
0.00
1.1
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
92
0.94
0.00
1.3
2.2
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
88
0.99
0.00
1.0
1.5
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
209.1
—
0
8
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
88
0.99
0.00
1.0
1.5
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_VASCDEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_VASCDEM | 2.669 [2.37, 3.01] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.188 |
During the follow-up period (1.1.1998 — 31.12.2019), 15971 out of 21397 females with F5_VASCDEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_VASCDEM | 3.066 [2.63, 3.58] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 11786 out of 15677 males with F5_VASCDEM died.
Mortality risk
Mortality risk for people of age
years, who have F5_VASCDEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.181% | 0.66% |
| 5 | 1.301% | 3.649% |
| 10 | 3.382% | 8.705% |
| 15 | 6.703% | 15.866% |
| 20 | 11.875% | 26.392% |
Relationships between endpoints
↥Index endpoint: F5_VASCDEM – Vascular dementia
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data